Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Jazz Pharmaceuticals plc, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Jazz Pharmaceuticals plc July 23, 202685.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −15 | $244.64 | $3,670 |
| Aug 31, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,840 | $241.39 | $444,158 |
| Aug 5, 2026 | Jazz Pharmaceuticals plc | Grant or award | +1,605 | — | — |
| May 22, 2026 | Jazz Pharmaceuticals plc | Open-market sale | −2,000 | $241.00 | $482,000 |
| Nov 20, 2025 | Jazz Pharmaceuticals plc | Option exercise | +3,415 | $138.08 | $471,543 |
| Nov 20, 2025 | Jazz Pharmaceuticals plc | Open-market sale | −3,415 | $177.78 | $607,119 |
| Aug 8, 2025 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,959 | $111.25 | $217,939 |
| Aug 7, 2025 | Jazz Pharmaceuticals plc | Grant or award | +3,507 | — | — |
| Aug 6, 2024 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,608 | $111.35 | $179,051 |
| Aug 2, 2024 | Jazz Pharmaceuticals plc | Grant or award | +3,731 | — | — |
| Aug 14, 2023 | Jazz Pharmaceuticals plc | Open-market sale | −1,344 | $138.16 | $185,687 |
| Aug 11, 2023 | Jazz Pharmaceuticals plc | Grant or award | +3,075 | — | — |
Questions about Heather Ann McSharry
What boards is Heather Ann McSharry on?
Heather Ann McSharry sits on the board of Jazz Pharmaceuticals plc.
How long has Heather Ann McSharry served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.